2050906-40-4 structure
|
Common Name | N/A | ||
|---|---|---|---|---|
| CAS Number | 2050906-40-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2050906-40-4BEBT-109 is a potent pan-mutant-selective EGFR inhibitor. BEBT-109 has improved pharmacokinetic properties. BEBT-109 can be used for multiple mutant-EGFR-driven non-small cell lung cancer (NSCLC) research[1]. |
| No information of Name |
| Description | BEBT-109 is a potent pan-mutant-selective EGFR inhibitor. BEBT-109 has improved pharmacokinetic properties. BEBT-109 can be used for multiple mutant-EGFR-driven non-small cell lung cancer (NSCLC) research[1]. |
|---|---|
| Related Catalog | |
| References |
| InChIKey | HLHLCZJZIOARRT-UHFFFAOYSA-N |
|---|---|
| SMILES | C=CC(=O)Nc1cc(Nc2nccc(-n3ccc4nc(OC)ccc43)n2)c(OC)cc1N(C)CCN(C)C |